Jarislowsky, Fraser LTD Gilead Sciences, Inc. Transaction History

Jarislowsky, Fraser LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $237,080 - $270,141	-4,185 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$62.1 - $78.08 $13,972 - $17,568	225 Added 5.68%	4,185 $264,000
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $286,466 - $332,640	3,960 New	3,960 $304,000
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $208,522 - $229,367	-3,384 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $211,533 - $233,496	3,384 New	3,384 $214,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Jarislowsky, Fraser LTD, based on Form 13F filings with the SEC.

Stay updated on Jarislowsky, Fraser LTD with notifications on news.